Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Ana López-Martín

Professor

Universidad Alfonso X el Sabio

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Articles (16)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (10)

Luis Cabezón-Gutiérrez

Head of oncology

SPAIN

View details

Sophie Postel-Vinay

Institut Gustave Roussy

FRANCE

View details

ATOCHA ROMERO

Associate Professor

Universidad CEU San Pablo

SPAIN

View details

Miguel Sánchez-Polán

Universidad Politécnica de Madrid

SPAIN

View details

Francisco Javier Otero Espinar

Catedrático

Universidade de Santiago de Compostela

SPAIN

View details

Mariano Provencio Pulla

Head of Medical Oncology Department at Puerta de Hierro University Hospital

Hospital Universitario Puerta del Hierro Majadahonda

SPAIN

View details

Moisés Marquina

Universidad Politécnica de Madrid

SPAIN

View details

Joaquim Bosch-Barrera

Professor Associat Doctor

Universitat de Girona

SPAIN

View details

Javier De Castro

Scientific Director

La Paz University Hospital

SPAIN

View details

Ignacio Refoyo

Profesor Titular de Universidad

Universidad Politécnica de Madrid

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ana López-Martín

Research Interests

Explore related searches

Articles (16)

From acute care to chronic disease management: integrating physical exercise into hospital settings

Real-world Safety and Effectiveness of Neoadjuvant Chemoimmunotherapy in Squamous Cell Lung Cancer: A Retrospective European Multicenter Study

Zongertinib to target HER2-driven resistance in EGFR mutation-positive NSCLC: a case report

Early pembrolizumab plasma levels as a prognostic biomarker in real-world NSCLC patients

Evaluation of the exposure-response relationship of pembrolizumab in non-small cell lung cancer: observational study protocol in real-world clinical practice

Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial

Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study)

KRAS Mutation Status in Non-Small Cell Lung Cancer Distribution Across Occupational Categories

Comprehensive molecular profiling of advanced NSCLC using NGS: Prevalence of druggable mutations and clinical trial opportunities in the ATLAS study

Analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/PD-L1

BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC

Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial

Early detection of disease progression in NSCLC patients undergoing immunotherapy through ctDNA analysis

Validation of the lung inmune prognostic (LIPI) index in first-line immunotherapy treatment of small cell lung carcinoma

Immunogenicity of COVID-19 vaccines in lung cancer patients.

Effects of Physical Activity Interventions on Self-Perceived Health Status among Lung Cancer Patients: Systematic Review and Meta-Analysis

Collaborators (10)

Luis Cabezón-Gutiérrez

Sophie Postel-Vinay

ATOCHA ROMERO

Miguel Sánchez-Polán

Francisco Javier Otero Espinar

Mariano Provencio Pulla

Moisés Marquina

Joaquim Bosch-Barrera

Javier De Castro

Ignacio Refoyo

Make your next move.